Influenza Diagnostics Market Size (2021-2031) and Growth
The Influenza Diagnostics Market is expected to register a CAGR of 6.03% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Type (Molecular Diagnostic Tests, Traditional Diagnostic Tests ); End User ( Reference Laboratories, Hospitals/Clinical Laboratories, Other End Users ). The global analysis is further broken-down at regional level and major countries. The report offers the value in USD for the above analysis and segments.
Purpose of the ReportThe report Influenza Diagnostics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Influenza Diagnostics Market Segmentation
Type- Molecular Diagnostic Tests
- Traditional Diagnostic Tests
- Reference Laboratories
- Hospitals/Clinical Laboratories
- Other End Users
Strategic Insights
Influenza Diagnostics Market Growth Drivers- Increase in Prevalence of Influenza: In 2021, the Centers for Disease Control & Prevention (CDC) stated that 9 million patients were affected by influenza. According to World Health Organization (WHO) February 2021 updates, WHO GISRS laboratories tested over 490,516 samples in 2021-2022. The rising cases influenza among the global population is driving the demand for influenza diagnostic tools for detection and prevention of the disease.
- Public Awareness and Government Initiatives: Increased awareness of influenza through health campaigns sponsored by the government will raise importance of early detecion leading to more patient seeking treatment. These in turn foster demand for influenza diagnostics.
- Increasing Geriatric Population: Huge growth in the elderly population acts as a fuel for the influenza diagnostics market. Older adults are prone to complications from influenza, and hence increased demand is experienced in the diagnostic testing for management of their health condition.
- Advanced Detection Technologies: The future influenza diagnostics developed with more sophisticated detection strategies, including next-generation sequencing and genomic technologies will make higher sensitivity and specificity possible, which will enable the quicker identification of the specific influenza viruses involved, therefore being much more supportive for designing suitable treatments for the diseases and controlling outbreaks.
- Universal Vaccine Strategies: Though the construction of pan-viral vaccines will be directed primarily toward developing vaccines, new technologies may have an impact on diagnosis. These vaccines are more effective at targeting conserved components of viruses and can therefore contribute to better identification of flu strains that would be used to alter diagnostic tests.
- Modular Diagnostic Platforms: Future diagnostic platforms will have to be developed with the ability to rapidly adapt to strains of influenza or other respiratory viruses, and so forth. The adaptability should help respond with a swiftness that is unprecedented healthcare system updates in the face of emerging threats.
- Rapid and Point-of-Care Testing: Development of rapid diagnostic tests that can be used at the point of care would bring lucrative growth opportunities in the influenza diagnostics market. Such tests will help healthcare providers diagnose influenza more rapidly in clinics, emergency rooms, and other settings, thus enabling rapid treatment and minimizing the spread of the virus.
- Multiplex Assays Development: Future diagnostics may include multiplex assays that can simultaneously detect multiple respiratory pathogens, amongst them several sub-types of influenza. It will streamline the processes of testing and improve the general efficiency of diagnostics in cases of respiratory illness creating opportunities for the market players.
- Integration of AI: The role of AI and machine learning in the diagnosis of influenza is going to be of great aid so as to provide results that are more accurate and come up sooner. Technologies in this regard have the facility for scanning voluminous datasets by identifying the prevailing patterns and predicting outbreaks, thus making responses against the influenza menace stronger.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Influenza Diagnostics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Influenza Diagnostics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The molecular diagnostic tests segment accounts for a higher revenue in product segment of the influenza diagnostics market in 2023.
Abbott, Quidel Corporation, BioMérieux, BD, F. Hoffmann-La Roche Ltd, Oxford Biosystems, Thermo Fisher Scientific, Meridian Bioscience, and Cepheid. are some of the major players operating in the influenza diagnostics market.
Asia Pacific region dominated the influenza diagnostics market in 2023
North America region dominated the influenza diagnostics market in 2023
The Influenza Diagnostics Market is estimated to witness a CAGR of 6.03% from 2023 to 2031
The major factors driving the influenza diagnostics market are:
1. Increase in Prevalence of Atrial fibrillation (AF)
2.Rising Awareness and Screening
3.Increasing Adoption Rate of Advanced Technologies
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Influenza Diagnostics Market - By Type
1.3.2 Influenza Diagnostics Market - By End User
1.3.3 Influenza Diagnostics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFLUENZA DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INFLUENZA DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INFLUENZA DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. INFLUENZA DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. INFLUENZA DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. INFLUENZA DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. MOLECULAR DIAGNOSTIC TESTS
7.3.1. Overview
7.3.2. Molecular Diagnostic Tests Market Forecast and Analysis
7.3.3. RT-PCR Market
7.3.3.1. Overview
7.3.3.2. RT-PCR Market Forecast and Analysis
7.3.4. Loop-Mediated Isothermal Amplification-Based Assays Market
7.3.4.1. Overview
7.3.4.2. Loop-Mediated Isothermal Amplification-Based Assays Market Forecast and Analysis
7.3.5. Nucleic Acid Sequence-Based Amplification Market
7.3.5.1. Overview
7.3.5.2. Nucleic Acid Sequence-Based Amplification Market Forecast and Analysis
7.3.6. Simple Amplification-Based Assays Market
7.3.6.1. Overview
7.3.6.2. Simple Amplification-Based Assays Market Forecast and Analysis
7.3.7. Other Molecular Diagnostic Tests Market
7.3.7.1. Overview
7.3.7.2. Other Molecular Diagnostic Tests Market Forecast and Analysis
7.4. TRADITIONAL DIAGNOSTIC TESTS
7.4.1. Overview
7.4.2. Traditional Diagnostic Tests Market Forecast and Analysis
7.4.3. Viral Culture Market
7.4.3.1. Overview
7.4.3.2. Viral Culture Market Forecast and Analysis
7.4.4. Serological Assays Market
7.4.4.1. Overview
7.4.4.2. Serological Assays Market Forecast and Analysis
7.4.5. Rapid Influenza Detection Market
7.4.5.1. Overview
7.4.5.2. Rapid Influenza Detection Market Forecast and Analysis
7.4.6. Direct Fluorescent Antibody Market
7.4.6.1. Overview
7.4.6.2. Direct Fluorescent Antibody Market Forecast and Analysis
8. INFLUENZA DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. REFERENCE LABORATORIES
8.3.1. Overview
8.3.2. Reference Laboratories Market Forecast and Analysis
8.4. HOSPITALS/CLINICAL LABORATORIES
8.4.1. Overview
8.4.2. Hospitals/Clinical Laboratories Market Forecast and Analysis
8.5. OTHER END USERS
8.5.1. Overview
8.5.2. Other End Users Market Forecast and Analysis
9. INFLUENZA DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Influenza Diagnostics Market Overview
9.1.2 North America Influenza Diagnostics Market Forecasts and Analysis
9.1.3 North America Influenza Diagnostics Market Forecasts and Analysis - By Type
9.1.4 North America Influenza Diagnostics Market Forecasts and Analysis - By End User
9.1.5 North America Influenza Diagnostics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Influenza Diagnostics Market
9.1.5.1.1 United States Influenza Diagnostics Market by Type
9.1.5.1.2 United States Influenza Diagnostics Market by End User
9.1.5.2 Canada Influenza Diagnostics Market
9.1.5.2.1 Canada Influenza Diagnostics Market by Type
9.1.5.2.2 Canada Influenza Diagnostics Market by End User
9.1.5.3 Mexico Influenza Diagnostics Market
9.1.5.3.1 Mexico Influenza Diagnostics Market by Type
9.1.5.3.2 Mexico Influenza Diagnostics Market by End User
9.2. EUROPE
9.2.1 Europe Influenza Diagnostics Market Overview
9.2.2 Europe Influenza Diagnostics Market Forecasts and Analysis
9.2.3 Europe Influenza Diagnostics Market Forecasts and Analysis - By Type
9.2.4 Europe Influenza Diagnostics Market Forecasts and Analysis - By End User
9.2.5 Europe Influenza Diagnostics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Influenza Diagnostics Market
9.2.5.1.1 Germany Influenza Diagnostics Market by Type
9.2.5.1.2 Germany Influenza Diagnostics Market by End User
9.2.5.2 France Influenza Diagnostics Market
9.2.5.2.1 France Influenza Diagnostics Market by Type
9.2.5.2.2 France Influenza Diagnostics Market by End User
9.2.5.3 Italy Influenza Diagnostics Market
9.2.5.3.1 Italy Influenza Diagnostics Market by Type
9.2.5.3.2 Italy Influenza Diagnostics Market by End User
9.2.5.4 Spain Influenza Diagnostics Market
9.2.5.4.1 Spain Influenza Diagnostics Market by Type
9.2.5.4.2 Spain Influenza Diagnostics Market by End User
9.2.5.5 United Kingdom Influenza Diagnostics Market
9.2.5.5.1 United Kingdom Influenza Diagnostics Market by Type
9.2.5.5.2 United Kingdom Influenza Diagnostics Market by End User
9.2.5.6 Rest of Europe Influenza Diagnostics Market
9.2.5.6.1 Rest of Europe Influenza Diagnostics Market by Type
9.2.5.6.2 Rest of Europe Influenza Diagnostics Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Influenza Diagnostics Market Overview
9.3.2 Asia-Pacific Influenza Diagnostics Market Forecasts and Analysis
9.3.3 Asia-Pacific Influenza Diagnostics Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Influenza Diagnostics Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Influenza Diagnostics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Influenza Diagnostics Market
9.3.5.1.1 Australia Influenza Diagnostics Market by Type
9.3.5.1.2 Australia Influenza Diagnostics Market by End User
9.3.5.2 China Influenza Diagnostics Market
9.3.5.2.1 China Influenza Diagnostics Market by Type
9.3.5.2.2 China Influenza Diagnostics Market by End User
9.3.5.3 India Influenza Diagnostics Market
9.3.5.3.1 India Influenza Diagnostics Market by Type
9.3.5.3.2 India Influenza Diagnostics Market by End User
9.3.5.4 Japan Influenza Diagnostics Market
9.3.5.4.1 Japan Influenza Diagnostics Market by Type
9.3.5.4.2 Japan Influenza Diagnostics Market by End User
9.3.5.5 South Korea Influenza Diagnostics Market
9.3.5.5.1 South Korea Influenza Diagnostics Market by Type
9.3.5.5.2 South Korea Influenza Diagnostics Market by End User
9.3.5.6 Rest of Asia-Pacific Influenza Diagnostics Market
9.3.5.6.1 Rest of Asia-Pacific Influenza Diagnostics Market by Type
9.3.5.6.2 Rest of Asia-Pacific Influenza Diagnostics Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Influenza Diagnostics Market Overview
9.4.2 Middle East and Africa Influenza Diagnostics Market Forecasts and Analysis
9.4.3 Middle East and Africa Influenza Diagnostics Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Influenza Diagnostics Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Influenza Diagnostics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Influenza Diagnostics Market
9.4.5.1.1 South Africa Influenza Diagnostics Market by Type
9.4.5.1.2 South Africa Influenza Diagnostics Market by End User
9.4.5.2 Saudi Arabia Influenza Diagnostics Market
9.4.5.2.1 Saudi Arabia Influenza Diagnostics Market by Type
9.4.5.2.2 Saudi Arabia Influenza Diagnostics Market by End User
9.4.5.3 U.A.E Influenza Diagnostics Market
9.4.5.3.1 U.A.E Influenza Diagnostics Market by Type
9.4.5.3.2 U.A.E Influenza Diagnostics Market by End User
9.4.5.4 Rest of Middle East and Africa Influenza Diagnostics Market
9.4.5.4.1 Rest of Middle East and Africa Influenza Diagnostics Market by Type
9.4.5.4.2 Rest of Middle East and Africa Influenza Diagnostics Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Influenza Diagnostics Market Overview
9.5.2 South and Central America Influenza Diagnostics Market Forecasts and Analysis
9.5.3 South and Central America Influenza Diagnostics Market Forecasts and Analysis - By Type
9.5.4 South and Central America Influenza Diagnostics Market Forecasts and Analysis - By End User
9.5.5 South and Central America Influenza Diagnostics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Influenza Diagnostics Market
9.5.5.1.1 Brazil Influenza Diagnostics Market by Type
9.5.5.1.2 Brazil Influenza Diagnostics Market by End User
9.5.5.2 Argentina Influenza Diagnostics Market
9.5.5.2.1 Argentina Influenza Diagnostics Market by Type
9.5.5.2.2 Argentina Influenza Diagnostics Market by End User
9.5.5.3 Rest of South and Central America Influenza Diagnostics Market
9.5.5.3.1 Rest of South and Central America Influenza Diagnostics Market by Type
9.5.5.3.2 Rest of South and Central America Influenza Diagnostics Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INFLUENZA DIAGNOSTICS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. INFLUENZA DIAGNOSTICS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. QUIDEL CORPORATION
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. F. HOFFMANN-LA ROCHE LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIOMéRIEUX
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BD
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. OXFORD BIOSYSTEMS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. THERMO FISHER SCIENTIFIC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MERIDIAN BIOSCIENCE
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CEPHEID
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ALTONA DIAGNOSTICS GMBH
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Abbott
2. Quidel Corporation
3. BioMérieux
4. BD
5. F. Hoffmann-La Roche Ltd
6. Oxford Biosystems
7. Thermo Fisher Scientific
8. Meridian Bioscience
9. Cepheid
10. altona Diagnostics GmbH
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For